These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 36066666)
21. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging. Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452 [TBL] [Abstract][Full Text] [Related]
22. Development of a New Folate-Derived Ga-68-Based PET Imaging Agent. Brand C; Longo VA; Groaning M; Weber WA; Reiner T Mol Imaging Biol; 2017 Oct; 19(5):754-761. PubMed ID: 28194631 [TBL] [Abstract][Full Text] [Related]
23. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma. Li Y; Zhang J; Gu J; Hu K; Huang S; Conti PS; Wu H; Chen K Mol Imaging Biol; 2020 Feb; 22(1):134-143. PubMed ID: 31044341 [TBL] [Abstract][Full Text] [Related]
24. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII. Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146 [TBL] [Abstract][Full Text] [Related]
25. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer. Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842 [TBL] [Abstract][Full Text] [Related]
26. STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy. Xu D; Lu X; Yang F; Jiang Z; Yang S; Bi L; Liu J; Shan H; Li D Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):641-655. PubMed ID: 37924341 [TBL] [Abstract][Full Text] [Related]
27. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144 [TBL] [Abstract][Full Text] [Related]
28. Comparison of two site-specifically (18)F-labeled affibodies for PET imaging of EGFR positive tumors. Su X; Cheng K; Jeon J; Shen B; Venturin GT; Hu X; Rao J; Chin FT; Wu H; Cheng Z Mol Pharm; 2014 Nov; 11(11):3947-56. PubMed ID: 24972326 [TBL] [Abstract][Full Text] [Related]
29. Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules. Cheng Z; De Jesus OP; Namavari M; De A; Levi J; Webster JM; Zhang R; Lee B; Syud FA; Gambhir SS J Nucl Med; 2008 May; 49(5):804-13. PubMed ID: 18413392 [TBL] [Abstract][Full Text] [Related]
30. PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog. Dijkgraaf I; Franssen GM; McBride WJ; D'Souza CA; Laverman P; Smith CJ; Goldenberg DM; Oyen WJ; Boerman OC J Nucl Med; 2012 Jun; 53(6):947-52. PubMed ID: 22570329 [TBL] [Abstract][Full Text] [Related]
31. Al Palangka CRAP; Hanaoka H; Yamaguchi A; Murakami T; Tsushima Y Ann Nucl Med; 2019 Oct; 33(10):733-739. PubMed ID: 31297699 [TBL] [Abstract][Full Text] [Related]
32. Synthesis, preclinical evaluation, and a pilot clinical imaging study of [ Xie Q; Liu T; Ding J; Zhou N; Meng X; Zhu H; Li N; Yu J; Yang Z Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3129-3140. PubMed ID: 33630145 [TBL] [Abstract][Full Text] [Related]
33. Preclinical and first-in-human evaluation of Zhou M; Wang X; Chen B; Xiang S; Rao W; Zhang Z; Liu H; Fang J; Yin X; Deng P; Zhang X; Hu S Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4312-4324. PubMed ID: 35831714 [TBL] [Abstract][Full Text] [Related]
34. Targeting Phosphatidylethanolamine with Fluorine-18 Labeled Small Molecule Probe for Apoptosis Imaging. Yuan G; Liu S; Ma H; Su S; Wen F; Tang X; Zhang Z; Zhao J; Lin L; Xiang X; Nie D; Tang G Mol Imaging Biol; 2020 Aug; 22(4):914-923. PubMed ID: 31828718 [TBL] [Abstract][Full Text] [Related]
35. Melanoma Imaging Using Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486 [TBL] [Abstract][Full Text] [Related]
36. One-step radiosynthesis and initial evaluation of a small molecule PET tracer for PD-L1 imaging. Miao Y; Lv G; Chen Y; Qiu L; Xie M; Lin J Bioorg Med Chem Lett; 2020 Dec; 30(24):127572. PubMed ID: 32979488 [TBL] [Abstract][Full Text] [Related]
37. GRPR-selective PET imaging of prostate cancer using [(18)F]-lanthionine-bombesin analogs. Carlucci G; Kuipers A; Ananias HJ; de Paula Faria D; Dierckx RA; Helfrich W; Rink R; Moll GN; de Jong IJ; Elsinga PH Peptides; 2015 May; 67():45-54. PubMed ID: 25797109 [TBL] [Abstract][Full Text] [Related]
38. A novel 18F-labeled two-helix scaffold protein for PET imaging of HER2-positive tumor. Miao Z; Ren G; Jiang L; Liu H; Webster JM; Zhang R; Namavari M; Gambhir SS; Syud F; Cheng Z Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):1977-84. PubMed ID: 21761266 [TBL] [Abstract][Full Text] [Related]
39. Radiosynthesis and preclinical evaluation of 3'-Aza-2'-[(18)F]fluorofolic acid: a novel PET radiotracer for folate receptor targeting. Betzel T; Müller C; Groehn V; Müller A; Reber J; Fischer CR; Krämer SD; Schibli R; Ametamey SM Bioconjug Chem; 2013 Feb; 24(2):205-14. PubMed ID: 23273015 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer. Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]